Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodies
US-2025320281-A1 · Oct 16, 2025 · US
Theraclone Sciences Inc patents
Theraclone Sciences Inc holds 27 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 27 |
| Recent patents | 8 |
| First publication | Jun 9, 2015 |
| Latest publication | Oct 16, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
US-12410243-B2 · Sep 9, 2025 · US
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
US-12312396-B2 · May 27, 2025 · US
Monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with broad and potent neutralizing activity
US-2024343782-A1 · Oct 17, 2024 · US
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
US-12018067-B2 · Jun 25, 2024 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodies
US-2025320281-A1 · Oct 16, 2025 · US
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
US-12410243-B2 · Sep 9, 2025 · US
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
US-12312396-B2 · May 27, 2025 · US
Monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with broad and potent neutralizing activity
US-2024343782-A1 · Oct 17, 2024 · US
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
US-12018067-B2 · Jun 25, 2024 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 27 |
| Chemistry & Metallurgy | 27 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Theraclone Sciences Inc have in patentsdb?
- Theraclone Sciences Inc is linked to 27 publications as assignee in our database.
- What technology areas does Theraclone Sciences Inc patent most?
- Top mapped technology areas by patent count: Human Necessities (27); Chemistry & Metallurgy (27).
- Is Theraclone Sciences Inc's patent activity growing?
- In our data, assignee counts were 3 in 2024 and 3 in 2025 (similar year over year).
- What are recent patents assigned to Theraclone Sciences Inc?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.